SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-281988
Filing Date
2022-11-10
Accepted
2022-11-10 08:10:34
Documents
13
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d405971d8k.htm   iXBRL 8-K 25613
2 EX-99.1 d405971dex991.htm EX-99.1 76072
  Complete submission text file 0001193125-22-281988.txt   237688

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA urgn-20221110.xsd EX-101.SCH 2850
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20221110_lab.xml EX-101.LAB 17997
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20221110_pre.xml EX-101.PRE 11258
7 EXTRACTED XBRL INSTANCE DOCUMENT d405971d8k_htm.xml XML 3355
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38079 | Film No.: 221375057
SIC: 2834 Pharmaceutical Preparations